| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
Related Subjects:Multiple System Atrophy (MSA) |Parkinson Plus syndromes |Parkinsonism |Idiopathic Parkinson disease |Progressive Supranuclear Palsy |Drug Induced Parkinson disease
Parkinson-plus syndromes are neurodegenerative disorders with parkinsonism plus additional features that distinguish them from idiopathic Parkinson’s disease. Early recognition is crucial for prognosis, symptomatic management, and appropriate multidisciplinary care.
| Syndrome | 🔑 Key Features | 🕵️ Diagnostic Clues | 💊 Management |
|---|---|---|---|
| 👀 Progressive Supranuclear Palsy (PSP) |
• Early postural instability → backward falls
• Vertical gaze palsy (downward > upward) is hallmark • Axial rigidity > limb rigidity • Frontal cognitive changes: apathy, executive dysfunction • Dysarthria & dysphagia early |
• MRI: “Hummingbird sign” – midbrain atrophy
• Clinical: early falls, vertical gaze limitation • Eye movement testing: slowed saccades, impaired voluntary gaze |
• Limited levodopa response
• Physiotherapy: balance & gait training • OT & speech therapy: swallowing, communication • Multidisciplinary palliative/supportive care |
| 🫀 Multiple System Atrophy (MSA) |
• Parkinsonism: often symmetrical
• Early autonomic failure: orthostatic hypotension, urinary incontinence, erectile dysfunction • Cerebellar features: ataxia, dysarthria • Pyramidal signs: spasticity, brisk reflexes |
• MRI: “Hot cross bun sign” – pontocerebellar atrophy
• Autonomic testing: tilt-table, post-void residuals • Poor levodopa responsiveness distinguishes from idiopathic PD |
• Symptomatic management: midodrine/fludrocortisone for orthostatic hypotension
• Bladder care: intermittent catheterisation if needed • Physiotherapy: gait & balance • Supportive MDT care: speech, nutrition, palliative planning |
| ✋ Corticobasal Degeneration (CBD) |
• Asymmetric limb rigidity & dystonia
• Alien limb phenomenon – involuntary, purposeful movements • Cortical sensory loss, apraxia • Cognitive decline: executive dysfunction |
• Clinically asymmetric parkinsonism
• Neuroimaging: asymmetric cortical atrophy • Levodopa response poor • Alien limb & apraxia are strong differentiators |
• Levodopa generally ineffective
• Physiotherapy/OT: limb coordination, mobility, adaptive devices • Speech therapy for dysarthria • Cognitive & caregiver support; MDT approach |
| 🌙 Lewy Body Dementia (LBD) |
• Early cognitive impairment: attention, visuospatial, executive
• Fluctuating cognition & alertness • Recurrent visual hallucinations • Parkinsonism: bradykinesia, rigidity • REM sleep behaviour disorder (RBD) |
• Dementia onset within 12 months of parkinsonism
• Neuroimaging: occipital hypometabolism on PET/SPECT • Levodopa may worsen hallucinations • Neuropsychiatric symptoms: depression, anxiety, hallucinations |
• AChE inhibitors (rivastigmine) for cognition & hallucinations
• Avoid typical antipsychotics ⚠️ (esp. haloperidol); atypicals with caution • Levodopa cautiously if parkinsonism disabling • Melatonin or clonazepam for REM sleep disorder • Supportive MDT care: OT, physiotherapy, caregiver support |
💡 Teaching tip: Emphasise early distinguishing features: falls in PSP, autonomic failure in MSA, asymmetric limb & alien limb in CBD, and early dementia with hallucinations in LBD. Early recognition improves symptom-targeted interventions and patient safety.